Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

 We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (PIT) Regulations, 2015 (as amended) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 02/04/19 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 01/04/2021 and will re-open after completion of 48 hours from the declaration of financial results for the quarter and year ended 31/03/21 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter and year ended 31/03/21 shall be intimated in due course. We request you to kindly take the above information on record.
31-03-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Credit Rating

 We hereby inform you that Credit Rating assigned to the Company has been revised by the Credit Rating Agency i.e CARE Ratings Limited ('CARE') as under: Facility/instrument Rating Rating Action Long -term bank facilities- Term loan CARE B; Stable (Single B; Outlook: Stable) Assigned Long-term Bank facilities-cc CARE B; Stable (Single B; Outlook: Stable) Revised from CARE D (Single D); Stable Outlook Assigned Long-term/Short-term Bank facilities CARE B; Stable/CARE A4 (Single B; Outlook: Stable/ A Four) Revised from CARE D/ CARE D (Single D/ Single D); Stable Outlook Assigned This is for your information and record.
25-02-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Financial Results For The Quarter And Nine Months Ended December 31St 2020

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2020. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31st December, 2020 is enclosed herewith. 2. Appointed M/s. SAV & Associates LLP as Secretarial Auditor for the financial year 2020-21 for the purpose of conducting Secretarial Audit. This may be taken as compliance under the Listing Regulations.
12-02-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Outcome Of The Board Meeting

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2020. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31st December, 2020 is enclosed herewith. 2. Appointed M/s. SAV & Associates LLP as Secretarial Auditor for the financial year 2020-21 for the purpose of conducting Secretarial Audit. This may be taken as compliance under the Listing Regulations.
12-02-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Considering The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On 31St December, 2020.

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results for the Quarter and nine months ended on 31st December, 2020.
05-02-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Shareholding for the Period Ended December 31, 2020

 Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
21-01-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2020 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record
19-01-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sangameshwar IyerDesignation :- Company Secretary and Compliance Officer
18-01-2021
Bigul

THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window

 We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (PIT) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 02.04.2019 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 01.01. 2021 and will re-open after completion of 48 hours from the declaration of financial results for the quarter and nine months ended 31.12. 2020 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the Company. Further the date of Board Meeting for considering the said financial results for the quarter and nine months ended 31.12. 2020 shall be intimated in due course.
31-12-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received the below mentioned intimation / request for Loss of Share Certificate / issuance of duplicate share certificate from the following shareholder: Name Folio No. Cert. No. Number of Shares Dist. No. From Dist. No. To RADHA KANT KESHARY 00004727 7141 100 3430001 3430100 We shall issue the duplicate Share Certificate only after the necessary formalities are carried out by the Shareholder. This may be taken as compliance under the Listing Regulations.
07-12-2020
Next Page
Close

Let's Open Free Demat Account